• 1537 Citations
  • 21 h-Index
19982019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Fusao Ikeda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 23 Similar Profiles
Hepatocellular Carcinoma Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences
Ribavirin Medicine & Life Sciences
Interferons Medicine & Life Sciences
Chronic Hepatitis C Medicine & Life Sciences
Serum Medicine & Life Sciences
Genotype Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

  • 1537 Citations
  • 21 h-Index
  • 122 Article

Adefovir Dipivoxil-induced Fanconi's Syndrome and Osteomalacia Following Multiple Bone Fractures in a Patient with Chronic Hepatitis B

Makita, T., Kanzaki, H., Ohnishi, H., Ikeda, A., Takaki, A., Wada, N., Takeuchi, Y., Yasunaka, T., Ikeda, F., Shiraha, H., Tanaka, Y., Nishihara, S., Murakawa, K., Kitamura, Y., Okada, H. & Sendo, T., Jan 1 2019, In : Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 139, 4, p. 641-645 5 p.

Research output: Contribution to journalArticle

Open Access
Fanconi Syndrome
Osteomalacia
Bone Fractures
Chronic Hepatitis B
Tenofovir
Hepatitis B Surface Antigens
End Stage Liver Disease
Liver
Liver Transplantation
Vaccination

A new hepatitis virus test with microliter-scale fingertip blood collection in Japan

Nanba, S., Ikeda, F., Takaguchi, K., Shimomura, Y., Yasunaka, T. & Okada, H., Jan 1 2018, In : Acta Medica Okayama. 72, 3, p. 283-287 5 p.

Research output: Contribution to journalArticle

Hepatitis A virus
Viruses
Japan
Blood
Hepatitis Viruses
Tricuspid Valve Insufficiency
Living Donors
Liver Transplantation
Pulmonary Artery
Pressure
2 Citations (Scopus)

Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial

Takehara, T., Sakamoto, N., Nishiguchi, S., Ikeda, F., Tatsumi, T., Ueno, Y., Yatsuhashi, H., Takikawa, Y., Kanda, T., Sakamoto, M., Tamori, A., Mita, E., Chayama, K., Zhang, G., De-Oertel, S., Dvory-Sobol, H., Matsuda, T., Stamm, L. M., Brainard, D. M., Tanaka, Y. & 1 others, Kurosaki, M., Jan 1 2018, (Accepted/In press) In : Journal of Gastroenterology.

Research output: Contribution to journalArticle

Ribavirin
Hepacivirus
Fibrosis
Safety
Genotype